Two Sigma Investments, LP Innoviva, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 483,812 shares of INVA stock, worth $9.26 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

483,812

Previous 539,724 10.36%

Holding current value

$9.26 Million

Previous $8.85 Million 5.49%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $913,042 - $1.12 Million	-55,912 Reduced 10.36%	483,812 $9.34 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $136,828 - $155,832	-9,502 Reduced 1.73%	539,724 $8.85 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $2.6 Million - $2.99 Million	178,312 Added 48.07%	549,226 $8.37 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $1.01 Million - $1.34 Million	82,368 Added 28.55%	370,914 $5.95 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $974,533 - $1.09 Million	-78,782 Reduced 21.45%	288,546 $3.75 Million
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $3.98 Million - $4.8 Million	349,537 Added 1964.68%	367,328 $4.68 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $1.71 Million - $2.17 Million	-159,595 Reduced 89.97%	17,791 $200,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $2.09 Million - $2.44 Million	177,386 New	177,386 $2.35 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $5.73 Million - $7.95 Million	-400,072 Reduced 49.12%	414,331 $6.12 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $6.19 Million - $8.15 Million	402,425 Added 97.68%	814,403 $15.8 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $1.76 Million - $2.07 Million	110,376 Added 36.6%	411,978 $7.11 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $3.94 Million - $5.2 Million	301,602 New	301,602 $5.04 Million
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $291,777 - $390,287	-31,273 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $438,281 - $614,781	-42,428 Reduced 57.57%	31,273 $327,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $230,971 - $306,756	-20,102 Reduced 21.43%	73,701 $1.03 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $214,128 - $402,117	26,403 Added 39.17%	93,803 $1.1 Million
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $692,872 - $969,212	67,400 New	67,400 $954,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $186,478 - $212,813	-14,235 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $3.92 Million - $5.75 Million	-286,642 Reduced 95.27%	14,235 $200,000
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $4.2 Million - $5.49 Million	300,877 New	300,877 $5.25 Million
Q2 2018 Aug 14, 2018	SELL	$13.44 - $17.59 $1.14 Million - $1.5 Million	-85,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $617,260 - $759,945	44,729 Added 111.07%	85,000 $1.42 Million
Q4 2017 Feb 14, 2018	SELL	$11.73 - $14.75 $906,705 - $1.14 Million	-77,298 Reduced 65.75%	40,271 $571,000
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $1.42 Million - $1.66 Million	117,569	117,569 $1.66 Million

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Innoviva, Inc. Transaction History